Times LIVE (blog) Egrifta Gets FDA Approval for HIV-Associated Lipodystrophy AIDSmeds.com HIV/AIDS Treatment News The drug, requiring once-daily injections, was approved to reduce visceral adipose tissue (VAT)— deep belly fat surrounding the liver, stomach and other ... Read more »
Review Of Fat Redistribution In People With HIV Finds Treatment Progress, But … – The AIDS Beacon
Review Of Fat Redistribution In People With HIV Finds Treatment Progress, But ... The AIDS Beacon ... Read more »
Theratechnologies’ Tesamorelin HIV Drug On the Road to FDA Approval – Tech Jackal
TopNews United Kingdom (blog) Theratechnologies' Tesamorelin HIV Drug On the Road to FDA Approval Tech Jackal The FDA advisory panel has unanimously agreed that a drug designed to reduce belly fat in HIV patients is safe to distribute. The FDA will still have the ... FDA Panel Gives Thumbs Up for Egrifta Medscape FDA Committee Unanimously Recommends Egrifta for Lipodystrophy AIDSmeds.com HIV/AIDS Treatment News all 65 news articles?? Read more »
FDA Panel Gives Thumbs Up for Egrifta – Medscape
TopNews United Kingdom (blog) FDA Panel Gives Thumbs Up for Egrifta Medscape ... to live with the unsightly accumulation of belly fat — an adverse effect of antiretroviral therapy — that immediately labeled them as "AIDS patients Read more »
Tesamorelin Clinical Trials Report Successful Reduction Of Fat Accumulation … – The AIDS Beacon (blog)
Tesamorelin Clinical Trials Report Successful Reduction Of Fat Accumulation ... The AIDS Beacon (blog) Patients receiving the drug saw their belly profiles improve, and also reported an improved body image Read more »
